Once-weekly vs every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial
Radiotherapy & Oncology Mar 23, 2018
Quon HC, et al. - Prostate stereotactic body radiotherapy (SBRT) regimens differ in time, dose, and fractionation. The impact of overall treatment time on quality of life (QOL) in patients with prostate cancer was determined herein. Prostate SBRT delivered once per week (QW) vs every other day (EOD) resulted in an improved acute bowel and urinary QOL. Patients should be counselled regarding the potential for reduced short-term toxicity and improved QOL with QW prostate SBRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries